Evidence map›Paper›PMID 25359773›Full record

ArticleThe Journal of biological chemistry2014

Simvastatin potently induces calcium-dependent apoptosis of human leiomyoma cells.

Mostafa A Borahay, Gokhan S Kilic, Chandrasekha Yallampalli, Russell R Snyder, Gary D V Hankins, Ayman Al-Hendy, Darren Boehning

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 73 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Metal Ions Within the Neuro-Immune-Tumor Axis.Journal of immunology research · 2026
    Review
  5. Article
  6. Simvastatin-loaded liposomal nanoparticles as treatment for adenomyosis in a patient-derived xenograft mouse model: a pilot study.Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. The Role of Nanomedicine in Benign Gynecologic Disorders.Molecules (Basel, Switzerland) · 2024
    Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Simvastatin-loaded liposome nanoparticles treatment for uterine leiomyoma in a patient-derived xenograft mouse model: a pilot study.Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology · 2022
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Mostafa A BorahayFrom the Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, Texas 77555, the Department of Biochemistry and Molecular Biology, University of Texas Health Sciences Center at Houston, Houston, Texas 77030, maboraha@utmb.edu.
Gokhan S KilicFrom the Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, Texas 77555.
Chandrasekha Yallampallithe Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas 77030, and.
Russell R SnyderFrom the Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, Texas 77555.
Gary D V HankinsFrom the Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, Texas 77555.
Ayman Al-Hendythe Department of Obstetrics and Gynecology, Georgia Regents University, Augusta, Georgia 30912.
Darren Boehningthe Department of Biochemistry and Molecular Biology, University of Texas Health Sciences Center at Houston, Houston, Texas 77030, Darren.F.Boehning@uth.tmc.edu.
The University of Texas at Austin · USThe University of Texas Medical Branch at Galveston · US

Funding

UTMB Clinical and Translational Science AwardUL1TR000071 · NCATS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI BRASIER, ALLAN R. · 2012 to 2014
$14.4M
WOMEN'S REPRODUCTIVE HEALTH RESEARCH CENTERK12HD001269 · NICHD · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI HANKINS, GARY D · 1998 to 2013
$5.0M
Mechanisms of Apoptotic Calcium SignalingR01GM081685 · NIGMS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI BOEHNING, DARREN F · 2007 to 2020
$4.3M
NCATS NIH HHS UL1 TR000071NCATS NIH HHS UL1TR000071NICHD NIH HHS 5K12HD001269-12NICHD NIH HHS K12 HD001269NIGMS NIH HHS 1R01GM081685-01NIGMS NIH HHS 3R01GM081685-03S1NIGMS NIH HHS R01 GM081685
6 · The paper itself

Abstract

Statins are drugs commonly used for the treatment of high plasma cholesterol levels. Beyond these well known lipid-lowering properties, they possess broad-reaching effects in vivo, including antitumor effects. Statins inhibit the growth of multiple tumors. However, the mechanisms remain incompletely understood. Here we show that simvastatin inhibits the proliferation of human leiomyoma cells. This was associated with decreased mitogen-activated protein kinase signaling and multiple changes in cell cycle progression. Simvastatin potently stimulated leiomyoma cell apoptosis in a manner mechanistically dependent upon apoptotic calcium release from voltage-gated calcium channels. Therefore, simvastatin possesses antitumor effects that are dependent upon the apoptotic calcium release machinery.

Indexed as

ApoptosisBlotting, WesternCalciumCalcium Channels, L-TypeCell CycleCell Line, TumorCell ProliferationCell SurvivalChelating AgentsCytosolDose-Response Relationship, DrugEgtazic AcidHumansHydroxymethylglutaryl-CoA Reductase InhibitorsLeiomyomaMAP Kinase Signaling System1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl esterCalciumCalcium Channels, L-TypeChelating AgentsEgtazic AcidHydroxymethylglutaryl-CoA Reductase InhibitorsMitogen-Activated Protein KinasesSimvastatinApoptosisCalciumCalcium ChannelCell ProliferationInositol Trisphosphate Receptor (InsP3R)LeiomyomaStatinTumorTumor Cell Biology

Identifiers

PMID25359773
PMCPMC4271198
OpenAlexW1981113527

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.